SEC Form 4 · accession 0001328255-15-000003
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Rush
Officer — Executive VP and CFO
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 8:24 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | May 11, 2015 | M | 2,301 | $10.06 | A | 2,301 | D | |
| Class A Common StockF1 | May 11, 2015 | F | 1,213 | $32.22 | D | 1,088 | D | |
| Class A Common StockF2 | May 11, 2015 | S | 1,088 | $29.68 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F3 | $10.06 | May 11, 2015 | M | 2,301 | D | — | Aug 30, 2023 | Class A Common Stock | 2,301 | 326,478 | D |
Explanation of responses
- F1Pursuant to the INC Research Holdings, Inc. (the "Issuer") 2010 Equity Incentive Plan, this is the fair market value based on a 20-day average of the closing prices of the Issuer's common stock for purposes of cancellation of shares to pay the exercise price and withholding taxes.
- F2The price represents the public offering price of $31.00 per share of Common Stock, par value $0.01 per share (each, a "Share"), of the Issuer, less the underwriting discount of $1.32 per Share.
- F3One half of the shares subject to this option vest yearly in five equal installments beginning on August 30, 2014, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.